Interleukin-2 based outpatient therapy of advanced renal call carcinoma;INTERLEUKIN-2-HALTIGE AMBULANTE THERAPIE DES METASTASIERENDEN NIERENZELLKARZINOMS

Medizinische Klinik

Volumn 91, Issue SUPPL. 3, 1996, Pages 38-43

  Atzpodien, J ^a   Kirchner, H ^a   Poliwoda, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; INTERLEUKIN 2;

ADULT; ADVERSE DRUG REACTION; AGED; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; AMBULATORY CARE; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PALLIATIVE CARE; RECOMBINANT PROTEINS; SURVIVAL RATE;

EID: 0029937419     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)